Showing results (1-10 of 391) with videos related to
Sort By:
Pageof 40
Expert Opinion on Drug Safety|June 12, 2014
Consequences of emergency contraceptives: the adverse effectsAnne Thomin, Valentin Keller, Emile Daraï, et al.Presse Medicale (Paris, France : 1983)|November 15, 2017
[Medical treatment of endometriosis: Hormonal treatment of pain, impact on evolution and future perspectives]Sophie Geoffron, Guillaume Legendre, Emile Daraï, et al.Presse Medicale (Paris, France : 1983)|November 25, 2017
[Creation of expert centers on endometriosis]Emile Daraï, Sofiane Bendifallah, Nathalie Chabbert-Buffet, et al.Journal of Gynecology Obstetrics and Human Reproduction|November 5, 2020
Artificial intelligence in medicine: A matter of joy or concern?Kamila Kolanska, Nathalie Chabbert-Buffet, Emile Daraï, et al.Journal of Clinical Medicine|August 27, 2021
Role of miRNAs in Normal Endometrium and in Endometrial Disorders: Comprehensive ReviewKamila Kolanska, Sofiane Bendifallah, Geoffroy Canlorbe, et al.Journal of Gynecology Obstetrics and Human Reproduction|January 30, 2022
Sickle cell disease and COVID-19 in pregnant womenKamila Kolanska, Radostina Vasileva, François Lionnet, et al.Journal of Clinical Medicine|May 14, 2022
Stimulation Duration in Patients with Early Oocyte Maturation Triggering Criteria Does Not Impact IVF-ICSI OutcomesSophie Stout, Yohann Dabi, Charlotte Dupont, et al.Journal of Clinical Medicine|October 13, 2021
Ulipristal Acetate Modifies miRNA Expression in Both Superficial and Basal Layers of the Human EndometriumKamila Kolanska, Maria Sbeih, Geoffroy Canlorbe, et al.Medecine Sciences : M/S|November 30, 2022
[Gender-affirming hormone therapy in transgender persons]Nicolaï Johnson, Nathalie Chabbert-BuffetBest Practice & Research. Clinical Obstetrics & Gynaecology|February 8, 2017
The history and use of the progesterone receptor modulator ulipristal acetate for heavy menstrual bleeding with uterine fibroidsPhilippe Bouchard, Nathalie Chabbert-BuffetPageof 40